This inventor holds 4 USPTO granted patents and 8 published patent applications and 2 EPO patents. Top assignees: Ospedale San Raffaele S.r.l., Enthera S.r.l.. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 56 
2 out of 3 Years Active: 2020-2025
Title: **Inventor Francesca D'Addio: Pioneering Advances in Antibody Therapeutics**
Introduction
Francesca D'Addio, an accomplished inventor based in Milan, Italy, has made significant contributions to the field of biotechnology, particularly focusing on therapeutic antibodies. With four patents to her name, she has demonstrated a strong commitment to advancing medical science and improving patient outcomes through her innovative work.
Latest Patents
Francesca's latest patents include groundbreaking inventions related to TMEM219 antibodies. The first patent describes antibodies or antigen-binding fragments that specifically bind to the IGFBP3 receptor, namely TMEM219. This invention entails methods for their production, pharmaceutical compositions containing these antibodies, and their therapeutic uses. The second patent focuses on an antibody that binds specifically to IGFBP3 without displacing the binding of IGF-I to IGFBP3, effectively reducing the binding of IGFBP3 to the TMEM219 receptor. Both patents highlight her commitment to advancing antibody-based therapies.
Career Highlights
Francesca has a notable career marked by her roles at prestigious institutions. She has worked at Ospedale San Raffaele S.r.l. and Enthera S.r.l., where her research has led to significant advancements in antibody therapeutics. Her innovative approaches and rigorous scientific methodologies have established her as a leading figure in her field.
Collaborations
Throughout her career, Francesca has collaborated with esteemed colleagues, including Paolo Fiorina, enhancing her research endeavors and contributing to the advancement of scientific knowledge. These partnerships have fostered a collaborative environment that encourages creativity and innovation in the pursuit of new therapeutic solutions.
Conclusion
Francesca D'Addio stands out as a prominent inventor in the realm of antibody therapeutics. Her innovative patents and collaborative efforts reflect her dedication to enhancing the medical field through scientific advancements. As her research continues to evolve, the impact of her contributions is expected to resonate in the realms of biotechnology and medicine for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile